Mondrian Investment Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $21.4K | Sell |
|
|||||
|
2024
Q4 | $20K | Sell |
|
|||||
|
2024
Q3 | $71.3M | Sell |
|
|||||
|
2024
Q2 | $108M | Sell |
|
|||||
|
2024
Q1 | $169M | Buy |
|
|||||
|
2023
Q4 | $117M | Buy |
|
|||||
|
2023
Q3 | $61.2M | Hold |
|
|||||
|
2023
Q2 | $64.1M | Hold |
|
|||||
|
2023
Q1 | $67.3M | Sell |
|
|||||
|
2022
Q4 | $69.9M | Sell |
|
|||||
|
2022
Q3 | $61.8K | Hold |
|
|||||
|
2022
Q2 | $66.5M | Buy |
|
|||||
|
2022
Q1 | $60.5M | Buy |
|
|||||
|
2021
Q4 | $56.8M | Buy |
|
|||||
|
2021
Q3 | $59.3M | Hold |
|
|||||
|
2021
Q2 | $63M | Buy |
|
|||||
|
2021
Q1 | $59.7M | Buy |
|
|||||
|
2020
Q4 | $58.9M | Buy |
|
|||||
|
2020
Q3 | $45.7M | Buy |
|
|||||
|
2020
Q2 | $54.5M | Sell |
|
|||||
|
2020
Q1 | $51.4M | Sell |
|
|||||
|
2019
Q4 | $72.8M | Hold |
|
|||||
|
2019
Q3 | $61.9M | Buy |
|
|||||
|
2019
Q2 | $61.4M | Buy |
|
|||||
|
2019
Q1 | $60.3M | Buy |
|
|||||
|
2018
Q4 | $48.9M | Buy |
|